James S. Blachly

6.0k citations

126 papers · 1.6k indexed · h-index 26

Co-authors: John C. Byrd Robert A. Baiocchi Michael R. Grever Shelley Orwick Clara D. Bloomfield Jessica Kohlschmidt Deedra Nicolet Krzysztof Mrózek
Topics: Acute Myeloid Leukemia Research (57 papers)Chronic Lymphocytic Leukemia Research (48 papers)Acute Lymphoblastic Leukemia research (18 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States United Kingdom Germany

In The Last Decade

James S. Blachly

112 papers receiving 1.6k citations

Peers

Countries citing papers authored by James S. Blachly

Since Specialization

Citations

This map shows the geographic impact of James S. Blachly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Blachly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Blachly more than expected).

Fields of papers citing papers by James S. Blachly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Blachly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Blachly. The network helps show where James S. Blachly may publish in the future.

Co-authorship network of co-authors of James S. Blachly

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Blachly. A scholar is included among the top collaborators of James S. Blachly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Blachly. James S. Blachly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies 2025 ·Leukemia ·(unknown),Deedra Nicolet,(unknown),Daelynn R. Buelow,Shelley Orwick,Charles T. Gregory,(unknown),(unknown),Jonathan E. Kolitz,Bayard L. Powell,William Blum,Maria R. Baer,John C. Byrd,Wendy Stock,Geoffrey L. Uy,Krzysztof Mrózek,Ann‐Kathrin Eisfeld,Xiaolin Cheng,Sharyn D. Baker,James S. Blachly	1
2	Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia 2024 ·SHILAP Revista de lepidopterología ·(unknown),Qiuhong Zhao,Andrew Stiff,Seema A. Bhat,Mirela Anghelina,Leslie A. Andritsos,James S. Blachly,Narendranath Epperla,Zeinab El Boghdadly,Michael R. Grever,Kerry A. Rogers	0
3	A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies 2024 ·Clinical Cancer Research ·Pinkal Desai,Sagar Lonial,Amanda F. Cashen,Manali Kamdar,Ian W. Flinn,Susan O’Brien,Jacqueline S. Garcia,Neha Korde,Javid J. Moslehi,(unknown),(unknown),Shringi Sharma,(unknown),(unknown),(unknown),(unknown),Jamal Saeh,Marcio Andrade‐Campos,Tapan M. Kadia,James S. Blachly	15
4	Association of social deprivation with survival in younger adult patients with AML: an Alliance study 2023 ·Blood Advances ·(unknown),Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Alice S. Mims,James S. Blachly,Shelley Orwick,Karilyn Larkin,Christopher C. Oakes,Andrew Hantel,Andrew J. Carroll,William Blum,Bayard L. Powell,Geoffrey L. Uy,Richard M. Stone,Richard A. Larson,John C. Byrd,Electra D. Paskett,Jesse J. Plascak,Ann‐Kathrin Eisfeld	5
5	BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors 2022 ·Blood Advances ·Daelynn R. Buelow,Bhavana Bhatnagar,Shelley Orwick,(unknown),Eric D. Eisenmann,(unknown),Navjotsingh Pabla,James S. Blachly,Sharyn D. Baker,Bradley W. Blaser	7
6	Challenges and Gaps in Clinical Trial Genomic Data Management 2022 ·JCO Clinical Cancer Informatics ·(unknown),(unknown),(unknown),W. Fraser Symmans,Yujia Wen,Charles M. Perou,James S. Blachly,James L. Chen,Benjamin G. Vincent,Daniel G. Stover	2
7	HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia 2022 ·Blood Advances ·(unknown),Hatice Gülçin Özer,Pierluigi Gasparini,Giovanni Nigita,Rosario Distefano,(unknown),(unknown),(unknown),Juan Gallegos,Sachet A. Shukla,Vinay K. Puduvalli,Jennifer A. Woyach,Rosa Lapalombella,James S. Blachly,John C. Byrd,Deepa Sampath	7
8	Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression 2020 ·Clinical Cancer Research ·Alison R. Walker,John C. Byrd,James S. Blachly,Bhavana Bhatnagar,Alice S. Mims,Shelley Orwick,Tara L. Lin,Howland E. Crosswell,Danjie Zhang,Mark D. Minden,Veerendra Munugalavadla,Lauren Long,Jinfeng Liu,(unknown),Thomas Oellerich,Hubert Serve,Arati V. Rao,William Blum	27
9	Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia 2020 ·Cancer Discovery ·Jennifer A. Woyach,James S. Blachly,Kerry A. Rogers,Seema A. Bhat,(unknown),Gerard Lozanski,David M. Weiss,Barbara L. Andersen,Michael Gulrajani,Melanie M. Frigault,Ahmed Hamdy,Raquel Izumi,Veerendra Munugalavadla,Cheng S. Quah,Minhui Wang,John C. Byrd	57
10	TP-0903 is active in models of drug-resistant acute myeloid leukemia 2020 ·JCI Insight ·(unknown),Daelynn R. Buelow,(unknown),Mingshan Niu,Eric D. Eisenmann,Kevin M. Huang,(unknown),(unknown),Clifford J. Whatcott,(unknown),Shelley Orwick,(unknown),(unknown),Lindsey T. Brinton,Rosa Lapalombella,James S. Blachly,Erin Hertlein,John C. Byrd,Bhavana Bhatnagar,Sharyn D. Baker	21
11	Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia 2020 ·Journal of Hematology & Oncology ·Lindsey T. Brinton,Pu Zhang,Katie Williams,(unknown),Shelley Orwick,(unknown),(unknown),Larry Beaver,(unknown),(unknown),Matthew Cannon,(unknown),Bonnie K. Harrington,Amy Lehman,John C. Byrd,Rosa Lapalombella,James S. Blachly	37
12	Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts 2020 ·NAR Genomics and Bioinformatics ·Charles T. Gregory,Apollinaire Ngankeu,Shelley Orwick,Esko A. Kautto,Jennifer A. Woyach,John C. Byrd,James S. Blachly	6
13	Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression 2019 ·Cancer Research ·Anees M. Dauki,James S. Blachly,Esko A. Kautto,Sameera Ezzat,Mohamed H. Abdel‐Rahman,Christopher C. Coss	29
14	Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia 2019 ·Cancer Discovery ·Anjali Cremer,Jana M. Ellegast,Gabriela Alexe,Elizabeth S. Frank,Linda S. Ross,S. Haihua Chu,Yana Pikman,Amanda L. Robichaud,Amy Goodale,Björn Häupl,Sebastian Mohr,Arati V. Rao,Alison R. Walker,James S. Blachly,Federica Piccioni,Scott A. Armstrong,John C. Byrd,Thomas Oellerich,Kimberly Stegmaier	26
15	Incidence and Type of Opportunistic Infections during Ibrutinib Treatment at a Single Academic Center 2017 ·Blood ·Kerry A. Rogers,Luay Mousa,Qiuhong Zhao,Tracy Wiczer,(unknown),(unknown),James S. Blachly,John C. Byrd,(unknown),Jeffrey A. Jones,Polina Shindiapina,Audrey M. Sigmund,Matthew B. Sullivan,Farrukh T. Awan,Jennifer A. Woyach	23
16	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category 2017 ·Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Alice S. Mims,Christopher J. Walker,James S. Blachly,Deedra Nicolet,Shelley Orwick,(unknown),Andrew J. Carroll,Bayard L. Powell,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	0
17	Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality 2016 ·Cancer Research ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Stefano Volinia,James S. Blachly,Deedra Nicolet,Christopher C. Oakes,(unknown),Shelley Orwick,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Albert de la Chapelle,Clara D. Bloomfield	16
18	Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia 2016 ·Cancer Discovery ·(unknown),Christopher J. Walker,Sandya Liyanarachchi,(unknown),(unknown),(unknown),Xiaomeng Huang,(unknown),(unknown),Parvathi Ranganathan,Ramiro Garzon,James S. Blachly,Denis C. Guttridge,Clara D. Bloomfield,Albert de la Chapelle,Ann‐Kathrin Eisfeld	13
19	HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia 2016 ·Clinical Cancer Research ·(unknown),Brett Ewald,(unknown),Chaomei Liu,Melanie Sulda,Dimitrios Papaioannou,Ramiro Garzon,James S. Blachly,William Plunkett,Deepa Sampath	53
20	MuCor: mutation aggregation and correlation 2016 ·Bioinformatics ·(unknown),(unknown),Gerard Lozanski,Clara D. Bloomfield,John C. Byrd,James S. Blachly	13

About James S. Blachly

James S. Blachly is a scholar working on Hematology, Genetics and Cancer Research, having authored 126 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (57 papers), Chronic Lymphocytic Leukemia Research (48 papers) and Acute Lymphoblastic Leukemia research (18 papers). The work is most often cited by research in Hematology (778 citations), Genetics (560 citations) and Cancer Research (277 citations). James S. Blachly has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include John C. Byrd, Robert A. Baiocchi, Michael R. Grever, Shelley Orwick, Clara D. Bloomfield, Jessica Kohlschmidt, Deedra Nicolet, Krzysztof Mrózek, Jonathan E. Kolitz and Richard M. Stone. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact